| __timestamp | Bio-Techne Corporation | Pharming Group N.V. |
|---|---|---|
| Wednesday, January 1, 2014 | 60716000 | 4042025 |
| Thursday, January 1, 2015 | 119401000 | 5279557 |
| Friday, January 1, 2016 | 140879000 | 8073913 |
| Sunday, January 1, 2017 | 199243000 | 44864073 |
| Monday, January 1, 2018 | 240636000 | 53488904 |
| Tuesday, January 1, 2019 | 264359000 | 65896361 |
| Wednesday, January 1, 2020 | 260583000 | 69968267 |
| Friday, January 1, 2021 | 324951000 | 92047281 |
| Saturday, January 1, 2022 | 372766000 | 131819000 |
| Sunday, January 1, 2023 | 378378000 | 87501000 |
| Monday, January 1, 2024 | 396826000 |
In pursuit of knowledge
In the ever-evolving biotech industry, effective cost management is crucial for sustaining growth and innovation. This analysis delves into the Selling, General, and Administrative (SG&A) expenses of two prominent players: Bio-Techne Corporation and Pharming Group N.V., from 2014 to 2023.
Bio-Techne Corporation has demonstrated a consistent upward trend in SG&A expenses, with a remarkable 550% increase over the decade, peaking at nearly $400 million in 2023. This growth reflects the company's strategic investments in expanding its operational capabilities and market reach. In contrast, Pharming Group N.V. experienced a more volatile trajectory, with expenses surging by over 3,000% from 2014 to 2022, before a notable decline in 2023.
These insights underscore the dynamic nature of cost management in biotech, highlighting the importance of strategic planning and adaptability in navigating financial challenges.
Who Optimizes SG&A Costs Better? Novo Nordisk A/S or Pharming Group N.V.
SG&A Efficiency Analysis: Comparing AstraZeneca PLC and Pharming Group N.V.
Who Optimizes SG&A Costs Better? Pfizer Inc. or Pharming Group N.V.
SG&A Efficiency Analysis: Comparing Biogen Inc. and Bio-Techne Corporation
Operational Costs Compared: SG&A Analysis of Intra-Cellular Therapies, Inc. and Bio-Techne Corporation
SG&A Efficiency Analysis: Comparing Bio-Techne Corporation and Grifols, S.A.
Cost Management Insights: SG&A Expenses for Bio-Techne Corporation and Vericel Corporation
Who Optimizes SG&A Costs Better? BioMarin Pharmaceutical Inc. or Pharming Group N.V.
Operational Costs Compared: SG&A Analysis of Pharming Group N.V. and Axsome Therapeutics, Inc.
Cost Management Insights: SG&A Expenses for Pharming Group N.V. and Opthea Limited
Breaking Down SG&A Expenses: Pharming Group N.V. vs ACADIA Pharmaceuticals Inc.
Who Optimizes SG&A Costs Better? Pharming Group N.V. or Agios Pharmaceuticals, Inc.